Table 1. Initial therapy for patients with Kawasaki disease

Agent	Description	Dose
IVIG	Pooled polyclonal immunoglobulin	IV, 2 g/kg over 8–12 h; consider slower infusion in KD shock or myocardial dysfunction
Aspirin	Acetylsalicylic acid	PO, 30–50 mg/kg/day divided every 6 h; 3–5 mg/kg/day once afebrile for 48–72 h

Data from Jone et al. [4].
IVIG: intravenous immunoglobulin; KD: Kawasaki disease; PO: by mouth.